Global Buzz: Hugel's Letybo FDA Approval in Aesthetic Medicine

Hugel, a global pharmaceutical company, received FDA approval for their new botulinum toxin, Letybo, marking a milestone in aesthetic medicine. Letybo offers a new option for anti-aging treatments, catering to physicians and patients seeking innovative solutions in the realm of non-surgical aesthetics. This development signifies progress in enhancing natural beauty, shaping the future of aesthetic medicine. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for ...